Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | RGEN | BLTE | ||
| Company | Protagonist Therapeutics Inc | Repligen Corp | Belite Bio Inc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.00 | 114.08 | 157.11 | ||
| High | 99.75 | 118.42 | 159.71 | ||
| Low | 97.20 | 112.97 | 155.64 | ||
| Latest | 98.97 | 118.31 | 159.16 | ||
| Change | +0.45 | +5.20 | +4.66 | ||
| % Change | +0.46% | +4.60% | +3.02% | ||
| Volume | 577,600 | 1,822,600 | 58,500 | ||
| 20-Day Average Volume | 688,370 | 958,250 | 133,420 | ||
| Previous Close | 98.52 | 113.11 | 154.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 102.48 | 122.07 | 167.00 | ||
| 20-Day Raw Stochastic | 30.78% | 27.57% | 18.25% | ||
| 20-Day Relative Strength | 49.42 | 45.76 | 45.93 | ||
| Weighted Alpha | +86.86 | -19.32 | +143.77 | ||
| Today's Opinion | 80% Buy | 72% Sell | 24% Buy | ||
| Previous Opinion | 80% Buy | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.56% since 04/23/26 | +3.73% since 04/23/26 | -3.22% since 04/23/26 | ||
| Low | 97.20 on 04/30/26 | 110.58 on 04/29/26 | 153.69 on 04/28/26 | ||
| High | 105.94 on 04/24/26 | 119.47 on 04/27/26 | 165.30 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | -0.90% since 03/30/26 | +6.12% since 03/30/26 | +6.69% since 03/30/26 | ||
| Low | 95.40 on 04/13/26 | 109.50 on 04/23/26 | 148.00 on 03/31/26 | ||
| High | 107.84 on 04/01/26 | 141.46 on 04/21/26 | 183.67 on 04/09/26 | ||
| 3-Month | |||||
| %Chg | +20.99% since 01/30/26 | -20.79% since 01/30/26 | -5.82% since 01/30/26 | ||
| Low | 77.00 on 02/23/26 | 109.50 on 04/23/26 | 146.61 on 03/24/26 | ||
| High | 107.84 on 04/01/26 | 160.88 on 02/03/26 | 200.00 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +27.13% since 10/30/25 | -18.16% since 10/30/25 | +62.24% since 10/30/25 | ||
| Low | 75.44 on 11/04/25 | 109.50 on 04/23/26 | 97.99 on 10/31/25 | ||
| High | 107.84 on 04/01/26 | 175.77 on 01/06/26 | 200.00 on 02/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,286,461 | 6,379,290 | 6,174,593 | ||
| Shares Outstanding, K | 63,809 | 56,399 | 39,965 | ||
| Annual Sales | 46,020,000 | 738,260,000 | 0 | ||
| Annual Net Income | -130,150,000 | 48,890,000 | -77,610,000 | ||
| Last Quarter Sales | 7,440,000 | 197,910,000 | 0 | ||
| Last Quarter Net Income | -44,380,000 | 13,290,000 | -25,320,000 | ||
| 60-Month Beta | 2.12 | 1.19 | -1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 02/25/26 | 0.49 on 02/24/26 | -0.38 on 03/02/26 | ||
| Earnings Date | 05/05/26 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 68.67 | 0.00 | ||